Experience with flutamide in previously untreated patients with advanced prostatic cancer. Academic Article uri icon

Overview

abstract

  • Twenty-one patients with advanced prostatic adenocarcinoma previously untreated with conventional endocrine therapy were treated with an oral non-steroidal antiandrogen, flutamide. There were 19 favorable responders, 1 failure and 1 equivocal response. Flutamide seems to be a safe antiandrogen, which is effective in the management of previously untreated patients with advanced prostatic carcinoma.

publication date

  • November 1, 1979

Research

keywords

  • Adenocarcinoma
  • Anilides
  • Flutamide
  • Prostatic Neoplasms

Identity

Scopus Document Identifier

  • 0018611530

PubMed ID

  • 501817

Additional Document Info

volume

  • 122

issue

  • 5